Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
Gabriela A., Project Coordinator at UT Health San Antonio, shared a post on LinkedIn:
”The FDA’s recent approval of ‘Ezplaz’, the first-ever-dried plasma product licensed in the United States, marks a major advancement in trauma care, particularly for military, emergency response, and other austere environments where traditional blood products are difficult to store and transport.
This milestone highlights the growing momentum behind blood preservation research, including TRC4-supported work at UTAustin, where investigators are exploring innovative thin-film freeze-drying approaches that could help shape the future of blood product storage, transport, and use in austere environments.
It’s exciting to see innovations once considered aspirational become reality, while groundbreaking research across The University of Texas System continues to transform bold ideas into real-world solutions.”
Stay uodated withย Hemostasis Today.
-
Aug 17, 2026, 17:03Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care in Fiji
-
Aug 17, 2026, 16:56Suspicion-Based Screening for Occult Malignancy in Lower Extremity Venous Thrombosis – JTH
-
Aug 17, 2026, 16:51Kathaleen Schnur: Celebrating The Bleeding Disorders Community
-
Aug 17, 2026, 16:45Eugenio Caradonna: Can Light Replace Chemicals in PRP Activation?
-
Aug 17, 2026, 16:30Jeff Sternlicht: We Donโt Measure Lp(a) Because We Have a Drug
-
Aug 17, 2026, 16:22Francesca Palandri: Why Is Ruxolitinib Response So Heterogeneous in Myelofibrosis?
-
Aug 17, 2026, 15:22Antoine Francis: The Hidden Power of Albumin
-
Aug 17, 2026, 15:01Alan Dursun: When Haemophilia Care Becomes a Reality
-
Aug 17, 2026, 14:58Registrations are Still Open for the EHC Health Economics Course 2026